Skip to main content
Premium Trial:

Request an Annual Quote

Genometrix Hires New Bioinformatics Director


THE WOODLANDS, Tex.--Genometrix here has appointed the scientist who founded and directed CuraGen's bioinformatics activities, Aleksandar Milosavljevic, to the position of senior director of bioinformatics. Genometrix develops DNA microarray technology for pharmaceutical, diagnostic, and genetics applications. Milosavljevic also previously managed the genomics group at Argonne National Laboratory, where he was responsible for processing and cataloging results of 1 million DNA chip experiments daily.

Genometrix CEO Mitch Eggers said Milosavljevic's role is critical to the company's future as "we develop information processing and database tools to handle the extremely large densities of information created by our high-throughput DNA analysis work stations." He added that currently, each Genometrix DNA workstation is capable of generating 6 billion bits of data per day. "With approximately 10 such workstations planned for our new facility opening mid-1999, the bioinformatics component is paramount to our business objective of providing the pharmaceutical industry with affordable genotyping services and database access for analyzing very large patient populations for the development of new genomic-based medicines," he added.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.